Press Releases Organogenesis Holdings Inc.

Equities

ORGO

US68621F1021

Market Closed - Nasdaq Other stock markets 21:00:00 13/05/2024 BST			5-day change	1st Jan Change
2.96 ^USD	-2.31%		+23.85%	-27.63%

01:01pm	Morgan Stanley Lowers Price Target on Organogenesis Holdings to $3 From $3.50, Keeps Equalweight Rating	MT
05-10	Health Care Edges Higher Amid Rotation to Utilities - Health Care Roundup	DJ

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Organogenesis: Q1 Earnings Snapshot	05-09	AQ
Organogenesis Holdings Inc. Reports First Quarter 2024 Financial Results	05-09	AQ
Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu® for Knee Osteoarthritis	05-02	AQ
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024	04-16	AQ
Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud Case	04-03	AQ
Organogenesis: Q4 Earnings Snapshot	02-29	AQ
Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Guidance	02-29	AQ
Organogenesis Holdings Inc. to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference	02-12	AQ
Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 29, 2024	02-08	AQ
HippoFi Hires World's Top Regenerative Therapy Expert, Dr. Gail Naughton, to Drive Commercialization Plans of its Proprietary Technologies	12-12	AQ
ORGANOGENESIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Organogenesis Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm	12-07	BU
Organogenesis: Q3 Earnings Snapshot	11-09	AQ
Organogenesis Holdings Inc. Reports Third Quarter 2023 Financial Results	11-09	AQ
Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2023 Financial Results on November 9, 2023	05/10/23	AQ
Organogenesis Applauds Withdrawal of Local Coverage Determinations by Novitas, First Coast Service Options and CGS	28/09/23	AQ
Organogenesis Holdings Inc. to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference	06/09/23	AQ
Organogenesis: Q2 Earnings Snapshot	09/08/23	AQ
Organogenesis Holdings Inc. Reports Second Quarter 2023 Financial Results; Withdraws Fiscal Year 2023 Guidance	09/08/23	AQ
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2023 Financial Results on August 9, 2023	10/07/23	AQ
Organogenesis: Q1 Earnings Snapshot	10/05/23	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Organogenesis Holdings Inc.

Equities

ORGO

US68621F1021

Press Releases

Filters